Rising Demand for Prenatal Screening and advanced molecular diagnostics Fuel a Steady 7.28% CAGR GrowthAustin, United States, April 21, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, The Zika ...

U.S. Dengue Testing Market is expected to grow at a steady rate, growing from USD 148.35 Million in 2025 to USD 223.40 Million in 2035 owing to high rapid diagnostic tests’ adoption ratesAustin, April ...

The global Sepsis Diagnostics Market is projected to grow steadily at an annual rate of around 7% over the next five years, ...

Founded in 2020, LEX Diagnostics originated from a TTP innovation programme to translate a breakthrough in ultra-fast thermal control into a commercially viable diagnostic solutio ...

A next-generation PCR system designed to help labs manage increasing workflow complexity with greater flexibility, speed and confidence in reproducible results Waltham, MASS., (April 16, 2026) – ...

A study of a real-world population underscores measurable residual disease thresholds indicative of the risk for relapse in NPM1-mutated AML, suggesting guidance in treatment decisions.

Accurate detection of PIK3CA mutations is essential for personalizing breast cancer treatment, particularly with ...

To address the limitations of binary pCR classification, Pusztai and colleagues developed the residual cancer burden (RCB) ...

CRISPR-Cas12a technology is emerging as a powerful tool for infectious disease diagnostics, combining precision with speed and portability. New one-pot and amplification-free systems are delivering ...

From diagnosing disease to guiding treatment, lab results fuel some of the most important decisions in medicine. Now, with smarter EHR integration and clinical decision support, these insights can be ...

Roche is handing over $595 million to bolster its Foundation Medicine business with a deal to snap up SAGA Diagnostics. | ...

Breast cancer is one of the most common malignancies worldwide, and mutations in the PI3K/AKT/mTOR (PAM) signaling pathway ...